Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Diafiltration of a protein solution into a new buffer is a common final step in biopharmaceutical manufacturing. However, the excipient concentrations in the retentate are not always equal to their corresponding concentrations in the new buffer (diafiltration buffer). This phenomenon was observed repeatedly during diafiltration of different therapeutic monoclonal antibodies in which the concentrations of histidine and either sorbitol or sucrose (depending on which was chosen for the diafiltration buffer) in the retentate were lower than in the diafiltration buffer. Experimental studies and theoretical analyses of the ultrafiltration/diafiltration (UF/DF) step were carried out to determine the primary causes of the phenomenon and to develop a mathematical model capable of predicting retentate excipient concentrations. The analyses showed that retentate histidine concentration was low primarily because of repulsive charge interactions between positively‐charged histidine molecules and positively‐charged protein molecules, and that volume exclusion effects were secondary for like‐charged molecules. The positively‐charged protein molecules generate an electrical potential that cause an uneven distribution of charged histidine molecules. This interaction was used to construct a mathematical model based on the Poisson‐Boltzmann equation. The model successfully predicted the final histidine concentration in the diafiltered product (retentate) from the UF/DF development and production runs, with good agreement across a wide range of protein and histidine concentrations for four therapeutic monoclonal antibodies. The concentrations of uncharged excipients (sorbitol or sucrose) were also successfully predicted using previously established models, with volume exclusion identified as the primary cause of differences in uncharged excipient concentrations in the retentate and diafiltration buffer. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2009
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sphere Packings, Lattices and Groups
Conway, J. H., & Sloane, N. J. A. (1993) · Grundlehren der mathematischen Wissenschaften · doi:10.1007/978-1-4757-2249-9 · Cited by 880
Cited by
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45
“The final stage often involves ultrafiltration/diafiltration (UF/DF) to formulate the product with stabilizing excipients to ensure its long-term stability and suitability for therapeutic use [22].”
Thakur, G., Hebbi, V., & Rathore, A. S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120456 · Cited by 31
Metadata
- Authors
- Miao, F., Velayudhan, A., DiBella, E., Shervin, J., Felo, M., Teeters, M., & Alred, P.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2009-07
- Volume
- 25
- Issue
- 4
- Pages
- 964-972
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2010567516
- Cited by
- 47
- References
- 1
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody. https://app.cochat.ai/papers/10.1002/btpr.168
- The paper
- Miao, F., Velayudhan, A., DiBella, E., Shervin, J., Felo, M., Teeters, M., & Alred, P. (2009). Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody. Biotechnology Progress. https://doi.org/10.1002/btpr.168
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.